BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10438468)

  • 21. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling.
    Ivanov VN; Krasilnikov M; Ronai Z
    J Biol Chem; 2002 Feb; 277(7):4932-44. PubMed ID: 11733515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
    Zhu Y; Culmsee C; Klumpp S; Krieglstein J
    Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury.
    Zhang X; Shan P; Alam J; Fu XY; Lee PJ
    J Biol Chem; 2005 Mar; 280(10):8714-21. PubMed ID: 15590660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes.
    Oh H; Fujio Y; Kunisada K; Hirota H; Matsui H; Kishimoto T; Yamauchi-Takihara K
    J Biol Chem; 1998 Apr; 273(16):9703-10. PubMed ID: 9545305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis.
    Conery AR; Cao Y; Thompson EA; Townsend CM; Ko TC; Luo K
    Nat Cell Biol; 2004 Apr; 6(4):366-72. PubMed ID: 15104092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells.
    Madge LA; Pober JS
    J Biol Chem; 2000 May; 275(20):15458-65. PubMed ID: 10748004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma.
    Hideshima T; Nakamura N; Chauhan D; Anderson KC
    Oncogene; 2001 Sep; 20(42):5991-6000. PubMed ID: 11593406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
    Xu Q; Briggs J; Park S; Niu G; Kortylewski M; Zhang S; Gritsko T; Turkson J; Kay H; Semenza GL; Cheng JQ; Jove R; Yu H
    Oncogene; 2005 Aug; 24(36):5552-60. PubMed ID: 16007214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
    Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
    Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ; Sriram S
    J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons.
    Yamashita T; Sawamoto K; Suzuki S; Suzuki N; Adachi K; Kawase T; Mihara M; Ohsugi Y; Abe K; Okano H
    J Neurochem; 2005 Jul; 94(2):459-68. PubMed ID: 15998296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y; Gardner A; Lichtenstein A
    Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism.
    Kortylewski M; Feld F; Krüger KD; Bahrenberg G; Roth RA; Joost HG; Heinrich PC; Behrmann I; Barthel A
    J Biol Chem; 2003 Feb; 278(7):5242-9. PubMed ID: 12456685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
    Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
    J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-talk between IL-6 and TGF-beta signaling in hepatoma cells.
    Yamamoto T; Matsuda T; Muraguchi A; Miyazono K; Kawabata M
    FEBS Lett; 2001 Mar; 492(3):247-53. PubMed ID: 11257503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway.
    Fukuda M; Longnecker R
    J Virol; 2004 Feb; 78(4):1697-705. PubMed ID: 14747535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.
    Horowitz JC; Lee DY; Waghray M; Keshamouni VG; Thomas PE; Zhang H; Cui Z; Thannickal VJ
    J Biol Chem; 2004 Jan; 279(2):1359-67. PubMed ID: 14576166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation.
    Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST
    Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod.
    Choudhari SR; Khan MA; Harris G; Picker D; Jacob GS; Block T; Shailubhai K
    Mol Cancer Ther; 2007 Jan; 6(1):112-21. PubMed ID: 17237271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.